Skip to content
PeptideRank
BluefitMD logo

Provider review

BluefitMD cost: From $325/mo tirzepatide

A real FDA warning letter, and a LegitScript badge that fails to verify.

FDA's own Feb 20, 2026 letter (MARCS-CMS 721446) cites BluefitMD-branded product labels that falsely suggest BluefitMD itself is the compounder, plus "same active ingredient as Ozempic®/Wegovy®" and "Mounjaro®/Zepbound®" claims FDA says imply approval. Separately, and independently found: the LegitScript seal embedded on every page (ID 38397132) does not resolve at LegitScript's own registry, the same failure mode as an invented ID.

Verified August 2026

Reviewed by Marcus Webb

Transparency scorecard

2 of 4 disclosed openly

What BluefitMD discloses about itself, read from its own pages — not estimated.

Pharmacy named & regulated

Disclosed

Names its compounding pharmacy and states a federal regulatory category (503A/503B), sourced to its own site.

State coverage published

Not disclosed

Publishes no state coverage list — availability is something you learn during signup.

A real price is published

Disclosed

A real dollar figure is published on its own site, not estimated.

No hidden commitment trap

Not disclosed

The advertised price requires a prepay, auto-refill, or other commitment we found and named.

This review's stake, stated plainlysome of the outbound links on this site are affiliate links; start a program through one and we may earn a commission at no extra cost to you. Straight about the rest, too: the write-ups say what each provider is actually worth, and a commission does not change a word of them. Full disclosure here.

At a glance

Visit BluefitMD

Pharmacy

503A pharmacy

Labs

Not stated

States

Not published

Ranked above it

Lttl logo

Lttl

Calls its pricing "Priced Honestly" — the headline rate needs a year paid upfront.

#1 on our Glutathione provider ranking, above BluefitMD at #23.

Read the Lttl review →
On this page

What it actually costs

What this price covers

Medication

Included

Provider visits

Included

Shipping

Not confirmed

Lab work

Not disclosed

Coaching

Not disclosed

The catch — Tirzepatide's headline is the 12-month prepay rate; the true no-commitment monthly price is 44% to 244% higher depending on dose. Sermorelin's own product page and checkout funnel are honest about the $249/mo standing price — the trap there is a separate sitewide nav banner (not the product page itself) advertising the cheaper prepay tier as if it were the going rate.

See plans at BluefitMD

Prices read from BluefitMD's own site · August 2026

What they advertise

Tirzepatide: BluefitMD's own site-wide lead-generation funnel (app.bluefitmd.com/tirzepatide) headlines "Tirzepatide Treatments As Low As $225/mo." — the 12-month prepay rate for its lowest (2.5mg) dose. Semaglutide: its own compounded semaglutide marketing page has since been taken down (it is gone; an archived snapshot shows a "Monthly Membership (No Commitment)" of $199/mo, discounted to "as low as $175/mo"), though the product remains purchasable through the same app.bluefitmd.com checkout funnel. Sermorelin: its product page and checkout funnel both headline "$249/mo" directly, though a sitewide nav teaser elsewhere advertises "As low as $159/mo* *With a 12-month package" instead.

What you actually pay

Tirzepatide: $325/month at the lowest (2.5mg) dose, confirmed on BluefitMD's own dose-specific "Monthly Membership (No Commitment)" checkout page — scaling to $475 (7.5mg/10mg), $675 (12.5mg), and $775/month (15mg), each confirmed the same way. Semaglutide: $199/month per its own (now-archived) "Monthly Membership (No Commitment)" price — not confirmed across a dose range the way tirzepatide's checkout was, since the live marketing page for this product has been taken down. Sermorelin: $249/month, stated identically as the standing "Monthly Membership" rate on both the marketing page and the checkout funnel — genuinely the true price, not a promo.

Money you will meet later

  • Every tirzepatide dose tier's checkout page shows an identical "SAVE $X" discount badge ($24/mo monthly, $124 for 3 months, $444 for 6 months, $1,488 for 12 months) regardless of dose — and on every dose tier checked, that badge amount does not match the struck-through "before" price and the current "after" price shown directly beside it.
  • Its own Return & Refund Policy states, "Due to the nature of our products, all sales are final," with a narrow 7-day exception only for damaged shipments — separate from the "cancel your membership anytime" language that stops future billing.

The bottom line

BluefitMD LLC (Sunbiz #P24000054174, a real Florida LLC active since August 2024, based at 1841 Lakewood Ranch Blvd, Lakewood Ranch, FL — the exact address its own FDA letter was mailed to) is a telehealth clinic selling compounded tirzepatide and semaglutide, compounded sermorelin, NAD+/MICC+B12/methylene blue, and testosterone therapy, with checkout running through a separate app.bluefitmd.com funnel. It came out of the same FDA enforcement wave as MEDVi, the one company excluded from this site outright over documented deepfaked patient photos and fabricated physician personas — but BluefitMD is not that. No independent journalism names it, no fabricated-persona pattern appears on its site, and there is no "individuals may be actors" hedge anywhere, only an ordinary illustrative-photo disclaimer on medication-vial images. That is the line between a knock worth publishing and a reason not to list a company at all, and BluefitMD stays on the right side of it. What remains is a real, dated FDA warning letter (MARCS-CMS 721446, February 20, 2026) citing two things: product labels pictured on BluefitMD's own site that identified "BluefitMD" as the compounder when it is not, and marketing claims — "Compounded Semaglutide (the same active ingredient as Ozempic® and Wegovy®)" and "Compounded Tirzepatide (the same active ingredient as Mounjaro® & Zepbound®)" — that FDA states imply the products were FDA-approved or evaluated for safety and effectiveness when they were not. Both claims were confirmed word for word on a Wayback Machine snapshot from February 6, 2026; the live compounded-tirzepatide and compounded-semaglutide pages both are dead today, and both are still live links in the site's own primary navigation. Independent of the FDA letter, its own LegitScript seal does not check out (see signal), and its own Policies page states pricing "remains consistent regardless of dosage adjustments" — contradicted by its own checkout, where the same tirzepatide product's true no-commitment monthly price scales from $325 at the lowest dose to $775 at the highest, more than doubling, with an identical "SAVE $X" badge shown at every dose tier regardless of the different prices around it.

BluefitMD appears on our sermorelin provider ranking, our tirzepatide provider ranking, our NAD+ provider ranking and our Glutathione provider ranking. Nothing on this page is a performance claim.

Who it is for, and who it is not

A good fit if

  • You want a direct 503A pharmacy category claim — BluefitMD's own About and Safety Info pages both state it plainly, unlike several peers here that hedge between 503A and 503B.
  • You've read BluefitMD's FDA warning letter and its current site side by side and are satisfied the specific mislabeled-compounder claim no longer appears (the live compounded-tirzepatide/semaglutide pages are gone entirely, though the products are still sold via a different checkout path).
  • You're pricing sermorelin specifically — its $249/mo standing price is genuinely undisguised, agreeing across its own product page and its own checkout funnel, a cleaner story than its own tirzepatide listing.

Look elsewhere if

  • An open FDA warning letter over how a company marketed compounded drugs is a hard line for you, regardless of what a check finds today.
  • You're budgeting off BluefitMD's own "As low as $225/mo" tirzepatide headline — the real no-commitment price, by dose, is $325 to $775/month, and its own Policies page's claim that price doesn't vary by dose is directly contradicted by its own checkout pages.
  • You check a LegitScript badge before trusting it — BluefitMD's own seal ID returns "Access Denied" at LegitScript's own registry, the same failure as a badge that was never real.

What BluefitMD offers

Tap any compound to read our plain-English guide — what the evidence shows, how it is dosed, and what it costs elsewhere.

What else BluefitMD sells

Also sells

Beyond what this board tracks, BluefitMD's own site names this additional compound — read live off the same product pages, not inferred.

  • SemaglutideFrom $199/mo

Who fills your prescription

503A pharmacy

BluefitMD names the pharmacy that fills your prescription.

What its own site says

"503A," stated directly and plain on two separate pages. BluefitMD's own About page: "BluefitMD connects you with licensed, U.S.-based 503A pharmacies that are state-regulated and audited for safety and quality." Its safety-info page repeats the category for the tirzepatide product specifically: "Prepared by licensed U.S.-based 503A pharmacies." No specific pharmacy is ever named by name anywhere on the site — the Policies page instead refers only to "a licensed pharmacy in our network."

What's the difference between 503A and 503B?

A 503A pharmacy compounds for one named patient; a 503B outsourcing facility manufactures in batches under CGMP. Neither is a quality guarantee on its own — a named facility is simply a fact you can check, and an unnamed “partner pharmacy network” is not. Compounded peptides are not FDA-approved.

Where you can get it

Not published

Not published as a list, and the site's own pages disagree with each other. BluefitMD's about page markets a "nationwide network of licensed providers and pharmacies," and its checkout intake collects a "State" field with no stated restriction — but the only document on the site that states an actual state SCOPE, its own HIPAA Compliant Privacy Policy PDF, says twice that it covers "Patients in Florida and New York" specifically. That document also contains an unedited template artifact ("Re acknowledges and respects these rights," with no company name filled in), so the two-state scope reads more like boilerplate than a real 48-state exclusion — but it is the only page on the site that states any scope at all.

The honest cons

The part they would rather you skipped

FDA issued BluefitMD a warning letter (MARCS-CMS 721446, February 20, 2026, Center for Drug Evaluation and Research), addressed to BluefitMD at 1841 Lakewood Ranch Blvd, Lakewood Ranch, FL 34211 — the identical address confirmed as BluefitMD LLC's own Florida corporate registration. The letter states FDA reviewed bluefitmd.com in December 2025 and found two things misbranded under FDCA §502(a)/§502(bb): first, "the compounded semaglutide and tirzepatide products displayed on your website identify 'BluefitMD' on the pictured label, suggesting BluefitMD is the compounder of those drugs when in fact it is not"; second, the site carried the claims "Compounded Semaglutide (the same active ingredient as Ozempic® and Wegovy®)" and "Compounded Tirzepatide (the same active ingredient as Mounjaro® & Zepbound®)," which FDA says falsely imply the products were FDA-approved or evaluated for safety and effectiveness when they were not. Both quoted claims were confirmed word for word on a Wayback Machine snapshot of bluefitmd.com/compounded-tirzepatide dated February 6, 2026 — after FDA's December 2025 site review and just before the letter. Today, both bluefitmd.com/compounded-tirzepatide and its compounded-semaglutide page are both dead, even though both remain live links in BluefitMD's own primary navigation on every page checked, and even though the products themselves are still sold through a separate app.bluefitmd.com checkout funnel found independently of the marketing site's own broken links. Independent of the FDA letter: BluefitMD's own footer embeds a LegitScript seal widget (ID 38397132) on every page checked; that ID does not resolve at LegitScript's own registry — exactly what a made-up ID returns, and not what two known-good IDs return (NexLife's 46376918 and Hone Health's 10842626 both resolve).

  • FDA warning letter (MARCS-CMS 721446, Feb 20, 2026) over a mislabeled-compounder claim and FDA-approval-implying marketing language — see this review's knock for the full, independently-verified finding.
  • Its own footer LegitScript seal (ID 38397132) does not resolve at LegitScript's own registry — the same failure as an invented ID.
  • Its own Policies page states pricing "remains consistent regardless of dosage adjustments" — contradicted by its own checkout, where the true tirzepatide price more than doubles by dose ($325 to $775/month), with an identical, mathematically-wrong "SAVE $X" badge shown at every dose tier.
  • Both "Compounded Semaglutide" and "Compounded Tirzepatide" — the exact two products its FDA letter is about — are live links in its own primary navigation that lead nowhere, even though the products remain purchasable through a different checkout path.
  • No comprehensive state list is published; the only document on the site stating any state scope at all (its HIPAA Privacy Policy) names just Florida and New York, contradicting its own "nationwide network" marketing language.
  • No pharmacy is named by name anywhere on the site — only the 503A category, and only "a licensed pharmacy in our network."

None of this is unique to BluefitMD — the whole category shares it.

How it compares

Read this before you buy

A provider comparison is half the decision. The other half is whether the compound does anything for you at all — and whether it is allowed where you compete. Growth-hormone secretagogues are banned in tested sport, year-round, and a prescription does not change that.

Ready to get started?

Prices and plans in this category change often — check BluefitMD's current pricing before you decide. Ours was read from their own site in August 2026.

See BluefitMD pricing

Facts on this page reflect BluefitMD's own public disclosures when we last checked them, in August 2026. Prices and terms change without notice — confirm on BluefitMD's site before you buy. Provider names and logos on this page identify the company under review; their use does not imply endorsement, sponsorship or affiliation. This page is informational and not medical advice; compounded peptides are not FDA-approved, and growth-hormone secretagogues are banned in tested sport year-round. See our disclosure and editorial policy.

BluefitMD

4 compounds, From $199/mo

Visit